Answers are grounded in this paper and cite their sources.
The human papillomavirus test (HPV) test could improve the (cost-) effectiveness of cervical screening by selecting women with a very low risk for cervical cancer during a long period. An analysis of a longitudinal study suggests that women with a negative Pap smear and a negative HPV test have a strongly reduced risk of developing cervical abnormalities in the years following the test, and that HPV testing lengthens the detectable stage by 2-5 years, compared to Pap smear detection alone.
No takes yet. Share an insight, caveat, or question.
Marie et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: